WASHINGTON – LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Two later-stage trials investigating LSD for treating anxiety are due to conclude in 2026, which could lead to the drug being approved for the common mental health condition ...

LSD is a drug often associated with the counter-culture of the 1960s. But it is being studied as a promising therapy for ...

Read full article: Kissimmee businesses encourage membership in neighborhood watch-style safety coalition Family of Salaythis Melvin files federal lawsuit against Orange County Sheriff’s Office Read ...

WASHINGTON — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in ...